Leukocyte migration inhibition assay in patients with prostate adenocarcinoma

The Prostate
G L WrightS M Sieg

Abstract

The leukocyte migration inhibition (LMI) assay was used to determine the cell-mediated immune reactivity of prostate cancer patients to putative tumor antigens present in potassium chloride extracts of surgically removed prostate tumor tissue. Using an extract prepared from prostate tumor tissue, inhibition of leukocyte migration was found more frequently in prostate tumor patients (61%) than in patients with benign prostate hyperplasia (37%), patients with nonprostate cancers (26%), or normal donors (10%). Control extracts prepared from normal prostate tissue, benign prostate hyperplasia tissue, and unrelated tumor tissue were statistically less reactive in the LMI assay than the prostate tumor extract when reacted against leukocytes from prostate tumor patients. These results suggest that the LMI assay might be potentially useful for measuring the tumor-directed, cell-mediated immune responses in patients with prostate cancer.

References

Dec 1, 1979·The Journal of Urology·P F SchellhammerR J Faulconer
Oct 1, 1978·The Journal of Urology·S S StefaniS S Clark
Nov 1, 1976·Journal of the National Cancer Institute·J L McCoyR B Herberman
Jun 1, 1975·The Journal of Urology·S BrosmanS Shacks
Feb 15, 1976·International Journal of Cancer. Journal International Du Cancer·K RiecheG Pasternak
Aug 1, 1974·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Kjaer
Aug 1, 1974·The Journal of Urology·W J CatalonaP B Chretien
Dec 16, 1969·Annals of the New York Academy of Sciences·J Fogh, H Fogh

❮ Previous
Next ❯

Citations

Apr 1, 1983·European Journal of Cancer & Clinical Oncology·R J AblinR A Bhatti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.